Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Liver Cirrhosis Market from 2024 to 2025?

The market for liver cirrhosis has experienced swift expansion in the past few years. The forecast entails a surge from $1.86 billion in 2024 to $2.01 billion in 2025, representing a compound annual growth rate (CAGR) of 8.3%. The noteworthy expansion during the historic era can be ascribed to the rising incidence of liver conditions, high levels of alcohol intake, an older demographic, enhanced healthcare spending, and escalating government initiatives.

What Is the Projected Market Size of the Liver Cirrhosis Market?

In the coming years, the market size for liver cirrhosis is predicted to witness a surge, ballooning to $2.74 billion by 2029, with a compound annual growth rate (CAGR) of 8.0%. The growth during this projected period can be credited to factors such as an increase in hepatitis infections, economic development, urbanization, shifts in lifestyle, and a rise in medical tourism. Significant trends during this forecasted period encompass progress in diagnostic tools, technological advancements, collaborations and alliances, the incorporation of artificial intelligence, and the application of holistic therapies.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=22040&type=smp

Who are the Major Competitors in the Liver Cirrhosis Market Outlook?

Major companies operating in the liver cirrhosis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca PLC, Abbott Laboratories, Novartis AG, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Novo Nordisk A/S, Viatris Inc., Grifols Therapeutics LLC, Shionogi Inc., Galectin Therapeutics Inc., NGM Biopharmaceuticals Inc., Madrigal Pharmaceuticals Inc., Akero Therapeutics Inc.

What Is Fueling Growth in the Liver Cirrhosis Market?

The surge in the intake of alcoholic beverages is predicted to drive the evolution of the liver cirrhosis market in the future. The term ‘alcohol consumption’ refers to the amount and frequency of alcohol intake. The rising popularity of alcohol can be attributed to its perceived stress-relieving properties, its role in social bonding, its media promotion, and increased accessibility in various locales. The primary treatment strategy for liver cirrhosis in patients who consume excessive amounts of alcohol revolves around managing liver damage through avoidance of alcohol, medications, and supplementary care, coupled with addressing alcohol addiction through therapy and rehabilitation. For instance, data from the National Drugs Library based in Ireland, as of March 2023, indicates that the per capita alcohol consumption for those aged 15 and above increased to 10.2 liters of pure alcohol in 2022, marking a 7.6% rise compared to 2021. Consequently, it’s clear that the escalation in alcohol consumption fuels the growth of the liver cirrhosis market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=22040&type=smp

Which Liver Cirrhosis Market Segments Are Growing the Fastest?

The liver cirrhosis market covered in this report is segmented –

1) By Type: Alcoholic Cirrhosis, Atrophic Cirrhosis, Biliary Cirrhosis, Cardiac Cirrhosis, Cryptogenic Cirrhosis

2) By Treatment: Antibiotics, Immunosuppressants, Other Treatments

3) By End Users: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Academic And Research Institutes, Other End Users

Subsegmentss:

1) By Alcoholic Cirrhosis: Compensated Alcoholic Cirrhosis, Decompensated Alcoholic Cirrhosis, Alcoholic Steatohepatitis (ASH)-Associated Cirrhosis

2) By Atrophic Cirrhosis: Post-necrotic Atrophic Cirrhosis, Macronodular Atrophic Cirrhosis, Micronodular Atrophic Cirrhosis

3) By Biliary Cirrhosis: Primary Biliary Cirrhosis (PBC), Secondary Biliary Cirrhosis, Autoimmune Biliary Cirrhosis

4) By Cardiac Cirrhosis: Right Heart Failure-Induced Cirrhosis, Chronic Passive Congestion Cirrhosis, Ischemic Hepatitis Cirrhosis

5) By Cryptogenic Cirrhosis: Non-Alcoholic Steatohepatitis (NASH)-Associated Cirrhosis, Idiopathic Cirrhosis, Metabolic Syndrome-Associated Cirrhosis

Which Industry Trends Are Shaping the Future of the Liver Cirrhosis Market?

Key players in the liver cirrhosis market are shifting their focus towards technological advancements in treatment strategies, such as designing and developing active implantable medical devices, to enhance patient recovery and widen therapeutic opportunities. These electronically powered implanted devices have been engineered to track, support, or ameliorate organ functionality within the body. For example, in December 2024, Sequana Medical NV, a medical device firm based in Belgium, was granted approval by the US FDA for its alfapump system – the primary active implantable medical device in the US for treating recurring or resistant ascites resulting from liver cirrhosis. This cutting-edge technology offers an automated, continuous solution for managing fluids by transferring the excess fluid in the abdomen to the bladder, thereby significantly diminishing the reliance on invasive therapeutic paracentesis. The alfapump has majorly attributing an uplift in patient recovery rates and bettering their quality of life, with an approximate target market of 70,000 patients within the United States.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/liver-cirrhosis-global-market-report

Which Countries Are Leading the Liver Cirrhosis Market?

North America was the largest region in the liver cirrhosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the liver cirrhosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=22040

This Report Delivers Insight On:

1. How big is the liver cirrhosis market, and how is it changing globally?

2. Who are the major companies in the liver cirrhosis market, and how are they performing?

3. What are the key opportunities and risks in the liver cirrhosis market right now?

4. Which products or customer segments are growing the most in the liver cirrhosis market?

5. What factors are helping or slowing down the growth of the liver cirrhosis market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model